Exponent (EXPO) Competitors $70.05 -0.90 (-1.27%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$70.05 0.00 (0.00%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXPO vs. FCN, DNB, VSEC, CBZ, HURN, ICFI, CRAI, ACTG, MG, and FCShould you be buying Exponent stock or one of its competitors? The main competitors of Exponent include FTI Consulting (FCN), Dun & Bradstreet (DNB), VSE (VSEC), CBIZ (CBZ), Huron Consulting Group (HURN), ICF International (ICFI), Charles River Associates (CRAI), Acacia Research (ACTG), Mistras Group (MG), and Franklin Covey (FC). These companies are all part of the "research & consulting services" industry. Exponent vs. Its Competitors FTI Consulting Dun & Bradstreet VSE CBIZ Huron Consulting Group ICF International Charles River Associates Acacia Research Mistras Group Franklin Covey FTI Consulting (NYSE:FCN) and Exponent (NASDAQ:EXPO) are both mid-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership. Do institutionals & insiders hold more shares of FCN or EXPO? 99.4% of FTI Consulting shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 1.8% of FTI Consulting shares are held by company insiders. Comparatively, 1.6% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is FCN or EXPO more profitable? Exponent has a net margin of 18.35% compared to FTI Consulting's net margin of 6.82%. Exponent's return on equity of 24.19% beat FTI Consulting's return on equity.Company Net Margins Return on Equity Return on Assets FTI Consulting6.82% 12.88% 7.90% Exponent 18.35%24.19%13.51% Do analysts rate FCN or EXPO? FTI Consulting presently has a consensus price target of $175.50, suggesting a potential upside of 6.72%. Given FTI Consulting's stronger consensus rating and higher possible upside, analysts plainly believe FTI Consulting is more favorable than Exponent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FTI Consulting 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Exponent 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, FCN or EXPO? FTI Consulting has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Which has stronger valuation & earnings, FCN or EXPO? FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFTI Consulting$3.70B1.44$280.09M$7.1023.16Exponent$558.51M6.33$109M$2.0035.03 Does the media refer more to FCN or EXPO? In the previous week, FTI Consulting had 4 more articles in the media than Exponent. MarketBeat recorded 13 mentions for FTI Consulting and 9 mentions for Exponent. FTI Consulting's average media sentiment score of 1.09 beat Exponent's score of 0.73 indicating that FTI Consulting is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FTI Consulting 6 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryFTI Consulting beats Exponent on 10 of the 16 factors compared between the two stocks. Get Exponent News Delivered to You Automatically Sign up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXPO vs. The Competition Export to ExcelMetricExponentConsulting IndustryBusiness SectorNASDAQ ExchangeMarket Cap$3.58B$6.80B$26.24B$10.14BDividend Yield1.69%1.70%2.74%4.60%P/E Ratio35.0323.4227.2425.98Price / Sales6.332.861,228.99181.19Price / Cash30.3516.7927.3460.44Price / Book8.455.527.776.29Net Income$109M$272.15M$199.55M$271.07M7 Day Performance-1.92%2.90%10.07%3.87%1 Month Performance-3.58%1.32%19.37%4.88%1 Year Performance-34.71%-7.07%53.13%26.12% Exponent Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXPOExponent3.1613 of 5 stars$70.05-1.3%N/A-33.4%$3.58B$558.51M35.031,168FCNFTI Consulting3.7032 of 5 stars$166.88-1.1%$175.50+5.2%-25.3%$5.46B$3.70B23.508,374Positive NewsDNBDun & Bradstreet2.8458 of 5 stars$9.16+0.5%$11.63+27.0%-18.6%$4.08B$2.38B-101.726,360Positive NewsHigh Trading VolumeVSECVSE2.7514 of 5 stars$167.36+0.7%$145.00-13.4%+92.6%$3.44B$1.08B149.431,400Positive NewsCBZCBIZ2.7176 of 5 stars$57.92-3.2%N/A-16.6%$3.23B$1.81B33.2910,000HURNHuron Consulting Group4.6225 of 5 stars$139.31-1.4%$171.50+23.1%+33.0%$2.44B$1.52B24.317,230Positive NewsShort Interest ↓ICFIICF International4.2213 of 5 stars$95.50+0.3%$128.20+34.2%-39.9%$1.75B$2.02B16.619,300Positive NewsShort Interest ↓CRAICharles River Associates3.3568 of 5 stars$192.90-0.7%$228.00+18.2%+22.5%$1.28B$687.41M23.35940ACTGAcacia Research0.8202 of 5 stars$3.38+2.4%N/A-30.7%$318.27M$247.81M-56.321,036MGMistras Group3.4852 of 5 stars$9.71-0.2%N/A-11.1%$306.87M$702.45M26.254,800News CoveragePositive NewsFCFranklin Covey4.0577 of 5 stars$19.20-0.6%$27.00+40.6%-50.5%$244.24M$287.23M24.311,084News CoveragePositive News Related Companies and Tools Related Companies FTI Consulting Alternatives Dun & Bradstreet Alternatives VSE Alternatives CBIZ Alternatives Huron Consulting Group Alternatives ICF International Alternatives Charles River Associates Alternatives Acacia Research Alternatives Mistras Group Alternatives Franklin Covey Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXPO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exponent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exponent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXPO Stock Alerts